Loading stock data…
$27.94-1.78 (-5.99%)
Hims & Hers Health, Inc.
Hims & Hers Health, Inc. in the Healthcare sector is trading at $27.94 with a market capitalization of $6.6B. Wall Street consensus targets $31.15 (13 analysts), implying a +11.5% move over the next 12 months. The stock is currently 57% below its 52-week high of $65.30, remaining 2.3% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $753.21M↑ | $608.10M↓ | $617.82M↑ | $598.98M↑ | $544.83M |
| Gross Profit | $480.80M↑ | $396.79M↓ | $444.44M↑ | $442.06M↑ | $416.20M |
| Operating Income | -$97.19M↓ | -$78.32M↓ | $9.19M↓ | $11.81M↓ | $26.72M |
| Net Income | -$86.29M↑ | -$92.11M↓ | $20.60M↑ | $15.77M↓ | $42.51M |
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and int...